Cystoscopy and Ureteroscopy Market Size & Forecast to 2031

Cystoscopy and Ureteroscopy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type [Cystoscope (Rigid and Flexible), and Ureteroscope (Flexible and Semi-Flexible)], Procedure (Stone Management, Bladder Cancer, Benign Prostatic Hyperplasia, and Others), Technology (Fiberoptic and Video), Usage Type (Reusable and Single Use), End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, South and Central America)

Publication Month : Aug 2025

  • Report Code : TIPRE00040986
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 305
Inquire Before Buy

PRICING

$4450

$3560

The Cystoscopy and Ureteroscopy Market size is projected to reach US$ 729.30 million by 2031 from US$ 459.11 million in 2024. The market is expected to register a CAGR of 6.9% from 2025 to 2031. 

Cystoscopy and Ureteroscopy Market Analysis

The increasing prevalence of urological diseases and development of technologically advanced and minimally invasive products are driving the cystoscopy and ureteroscopy market growth. Additionally, increasing awareness about urological problems and increasing awareness among the large population about urological disorders contribute to market growth. Expansion in emerging markets is expected to create ample opportunities for cystoscopy and ureteroscopy market in the coming years.

Cystoscopy and Ureteroscopy Market Overview

North America is projected to dominate the cystoscopy and ureteroscopy market, accounting for the largest share during the forecast period. Moreover, Asia Pacific is expected to register a significant CAGR during the forecast period owing to the aging population and an increase in urological disorders such as urinary tract infections and bladder cancer. Enhanced healthcare infrastructure, more hospitals, and a rise in ambulatory surgical centers in China, India, Japan, and South Korea have led to greater procedural volumes and the adoption of minimally invasive techniques. Technological advancements, such as flexible and digital video cystoscopes and ureteroscopes, offer improved patient comfort and high-definition imaging while reducing infection risks through disposable designs.

The entry of global leaders like Olympus and Stryker has fostered competition and accelerated innovation. Medical tourism in Singapore and Thailand further fuels demand for specialized urological treatments. Additionally, increased healthcare awareness and urbanization contribute to the rising incidence of urological conditions, creating a growing preference for outpatient procedures that require efficient and user-friendly cystoscopes and ureteroscopes.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Cystoscopy and Ureteroscopy Market: Strategic Insights

cystoscopy-and-ureteroscopy-market
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst
Cystoscopy and Ureteroscopy Market Drivers and Opportunities

Market Drivers:

  • Increasing Prevelance of Urological Diseases:

    The increasing prevalence of kidney stones, bladder cancer, prostate enlargement, urinary tract infections (UTIs), and other medical conditions related to the bladder and kidneys propels the demand for cystoscopy and ureteroscopy procedures for early diagnosis and treatment.
  • Development of Technologically Advanced and Minimally Invasive Products:

    Technological developments in cystoscopy and ureteroscopy techniques have paved the way for the development of highly efficient and effective, and less invasive diagnostic and therapeutic options for urological diseases.
  • Rising Awareness of Screening Program:

    National and regional screening initiatives for bladder and kidney health promote early detection and enhanced awareness leads to increased procedural volume for both diagnostic and therapeutic purposes.

Market Opportunities:

  • Expansion in Emerging Economies:

    Rapid economic growth drives investments in healthcare infrastructure and new medical technologies in countries such as China, India, and South Africa. Initiatives taken toward the reinforcement of healthcare sectors include efforts to modernize urological care, raise awareness about early diagnosis, and expand health insurance coverage.
  • Adoption of Single-use Cystoscopes and Ureteroscopes:

    Increasing demand for infection control, cost-effectiveness, and regulatory pressure on reprocessing reusable scopes are creating a surge in single-use endoscope adoption. This trend opens up opportunities for manufacturers to offer cost-competitive, high-performance disposable cystoscopes and ureteroscopes.
  • Public-Private Partnerships and Government Funding:

    Governments are increasingly supporting early cancer detection programs, kidney health initiatives, and digital health infrastructure. This opens doors for public procurement contracts and strategic partnerships.
 

Cystoscopy and Ureteroscopy Market Report Segmentation Analysis

The cystoscopy and ureteroscopy market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in most industry reports:

By Product Type:

  • Cystoscope:

    Cystoscopes feature high-definition imaging, 3D visualization, and fluorescence technologies, which enhance their diagnostic precision. Moreover, innovations such as flexible, miniaturized designs and improved light sources contribute to better access to hard-to-reach areas along with greater patient comfort. Additionally, the integration of artificial intelligence aids in the early detection of abnormalities, further improving diagnostic accuracy.
  • Ureteroscope:

    Ureteroscopes features high-definition imaging, enhanced flexibility, and improved light sources, which enable more precise diagnostics and minimally invasive functionality. Innovations such as digital imaging and laser technology have revolutionized processes such as stone removal and tissue biopsies. Additionally, newer models are designed to be more compact and easier to operate, which improves patient comfort and surgical outcomes.

By Procedure:

  • Stone Management:

    Cystoscopy and ureyeroscopy ureteroscopy aids in stone management by allowing direct visualization and removal of stones from the urinary tract using minimally invasive techniques. It reduces recovery time, minimizes complications, and provides effective treatment options, such as laser lithotripsy for stone fragmentation and extraction.
  • Bladder Cancer:

    This procedure allows for the identification of tumors, abnormal growths, or lesions and facilitates biopsy or resection of any suspicious tissue.
  • Benign prostatic hyperplasia: 

    Technological innovations have led to significant advancements in the diagnosis and treatment of BPH in recent years. New therapy regimens now prioritize minimally invasive procedures, which help reduce recovery time and improve patient outcomes.
  • Others: 

    Cystoscopes and ureteroscopes are required in procedures such as the treatment of ureteral obstruction, tumor removal from the ureter or renal pelvis, and the placement of ureteral stents

By Technology:

  • Fiber optic:

    Fiber optic technology plays a crucial role in cystoscopy and ureteroscopy, enabling healthcare providers to visualize the bladder and urinary tract with exceptional clarity.
  • Video:

    Video technology in cystoscopy and ureteroscopy has transformed the examination of the bladder and urinary tract by providing high-quality, real-time digital imaging.

By Usage Type:

  • Reusable:

    Reusable cystoscopy and ureteroscopy instruments are crucial for examining the bladder and urinary tract, providing a cost-effective and sustainable alternative to disposable devices.
  • Single Use:

    Single-use cystoscopes and ureteroscopes have become popular due to their convenience and enhanced safety, partly owing to the reduced risk of infection.

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Geography:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

The cystoscopy and ureteroscopy market in North America is expected to hold a significant share of the market. Increasing incidence of kidney stones (urolithiasis), bladder cancer, and urinary tract infections by the market players are factors likely to drive the market.

Cystoscopy and Ureteroscopy Market Report ScopeCystoscopy and Ureteroscopy Market Share Analysis by Geography

Asia Pacific is expected to grow the fastest in the next few years. Emerging markets in Latin America, the Middle East, and Africa also have many untapped opportunities for cystoscopy and ureteroscopy providers to expand.

The cystoscopy and ureteroscopy market grows differently in each region. This is because of factors like increasing prevalence of increasing incidence of kidney stones (urolithiasis), bladder cancer, BPH and urinary tract infections along with new product launches and innovation. Below is a summary of market share and trends by region:

1. North America

  • Market Share:

    Holds a significant portion of the global market
  • Key Drivers:

    • Increasing incidence of kidney stones (urolithiasis), bladder cancer, and urinary tract infections
    • Technological Advancement
    • Robotics and wireless connectivity
  • Trends:

    R&D and strategic collaborations to accelerate product launches and market penetration.

2. Europe

  • Market Share:

    Substantial share due to Increasing prevalence of urological disorders
  • Key Drivers:

    • Increasing prevalence of urological conditions
    • Intensified research and development activities
    • The launch of advanced technologies across Europe
  • Trends:

    Strategic involvement of leading medical technology firms

3. Asia Pacific

  • Market Share:

    Fastest-growing region with rising market share every year
  • Key Drivers:

    • Increasing incidence of bladder cancer, kidney stones, UTIs, and prostate-related disorders in countries
    • Rapid improvements in healthcare infrastructure, supported by increasing government investments in public health.
  • Trends:

    Gradual adoption of digital imaging systems, HD cystoscopes, and AI-assisted diagnostics especially in advanced hospitals

4. South and Central America

  • Market Share:

    Growing market with steady progress
  • Key Drivers:

    • Rising rates of kidney stones, bladder cancer, prostate issues, and urinary tract infections
    • Growing Healthcare Investments and Infrastructure Development
  • Trends:

    Rising Interest in AI and Digital Health

5. Middle East and Africa

  • Market Share:

    Although small, but growing quickly
  • Key Drivers:

    • Expanding Healthcare infrastructure
    • Medical Tourism and International Patient Flow
  • Trends:

    Public Health Focus on Early Diagnosis and Cancer Care.

Cystoscopy and Ureteroscopy Market Players Density: Understanding Its Impact on Business Dynamics

 

High Market Density and Competition

Competition is strong due to the presence of established players such as Olympus Corp, Karl Storz SE & Co KG, Richard Wolf GmbH, Ambu A/S,. Regional and niche providers like Rudra Surgicals Advin Healthcare Pvt Lts are also adding to the competitive landscape across different regions.

This high level of competition urges companies to stand out by offering:

  • Advanced Products
  • Competitive pricing models
  • Complaince with regulatory guidelines

Opportunities and Strategic Moves

  • Increasing use of single-use cystoscope and ureteroscope is expected to prevent cross contamination also avoid reprocessing which is time consuming process which inturn reduces the cost of maintenance
  • Companies are emphasizing clinical studies and regulatory approvals (including FDA clearances for new product categories), building strong clinical evidence to support adoption in hospitals and outpatient settings.
  • Companies are targeting high-growth, under-penetrated markets in Asia-Pacific and Latin America for expansion, building local partnerships and increasing training initiatives. Manufacturers from Asia Pacific region are launching hybrid and price-competitive solutions for emerging markets, while Western start-ups innovate with AI software overlays that can bolt onto existing video stacks.

Major Companies operating in the Cystoscopy and Ureteroscopy Market are:

  1. Olympus Corp
  2. Karl Storz SE & Co KG
  3. Richard Wolf GmbH
  4. Ambu A/S
  5. PENTAX Medical
  6. Advin Health Care Pvt Ltd
  7. Coloplast Corp
  8. Cook Medical Holdings LLC
  9. Electronics Services Centre (ESC Medicams)
  10. Stryker Corp
  11. Rudra Surgicals
  12. Laborie
  13. Teleflex Inc
  14. NIDHI MEDITECH SYSTEMS
  15. Pioneer Healthcare Technologies
  16. Boston Scientific Corp
  17. Ottomed Endoscopy
  18. Becton Dickinson and Co
  19. SCHÖLLY FIBEROPTIC GMBH
  20. MicroPort Scientific Corp

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analysed during the course of research:

  1. EMS Electro Medical Systems S.A.
  2. Lumenis Ltd.
  3. Polydiagnost GmbH
  4. ProSurg Inc.
  5. SIMEON Medical GmbH & Co.?KG
  6. OTU Medical Inc.
  7. NeoScope Inc.
  8. Elmed Medical Systems
  9. Maxer Endoscopy GmbH (Erbe Vision)
  10. ROCAMED
  11. Zhuhai PUSEN Medical Technology Co., Ltd.
  12. InnoMedicus
  13. Dornier MedTech GmbH
  14. Vimex Endoscopy
  15. LocaMed Limited
  16. Cantel Medical Corporation

Cystoscopy and Ureteroscopy Market News and Recent Developments

  • Olympus Announces FDA Clearance of RenaFlex, Its First Single-use Flexible Ureteroscope

    Olympus, a global medical technology company committed to making people’s lives healthier, safer, and more fulfilling, announced the U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex, with full market availability. The RenaFlex single-use flexible ureteroscope system is used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.
  • Boston Scientific Receives FDA Clearance for LithoVue Elite Single-Use Digital Flexible Ureteroscope System

    Boston Scientific Corporation announced US Food and Drug Administration (FDA) 510(k) clearance of the LithoVue Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures. The built-in pressure sensor on the LithoVue Elite ureteroscope tip is designed to allow urologists to make informed, pressure-related clinical decisions.

Cystoscopy and Ureteroscopy Market Report Coverage and Deliverables

The "Cystoscopy and Ureteroscopy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

  • Cystoscopy and Ureteroscopy Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Cystoscopy and Ureteroscopy Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
  • Detailed PEST and SWOT analysis
  • Cystoscopy and Ureteroscopy Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
  • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Cystoscopy and Ureteroscopy Market
  • Detailed company profiles
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What would be the estimated value of the cystoscopy and ureteroscopy market by 2031?

The cystoscopy and ureteroscopy market is estimated to reach a value of US$ 729.30 million by 2031.

What is the expected CAGR of the cystoscopy and ureteroscopy market?

The cystoscopy and ureteroscopy market is estimated to register a CAGR of 6.9% during the forecast period.

Which are the leading players operating in the cystoscopy and ureteroscopy market?

Olympus Corp, Karl Storz SE & Co KG, Richard Wolf GmbH, Ambu A/S, PENTAX Medical, Advin Health Care Pvt Ltd, Coloplast Corp, Cook Medical Holdings LLC, Electronics Services Centre (ESC Medicams), Stryker Corp, Rudra Surgicals, Laborie, Teleflex Inc, NIDHI MEDITECH SYSTEMS, Pioneer Healthcare Technologies, Boston Scientific Corp, Ottomed Endoscopy, Becton Dickinson and Co, SCHÖLLY FIBEROPTIC GMBH, and MicroPort Scientific Corp are among the key players operating in the cystoscopy and ureteroscopy market.

What are the factors driving the cystoscopy and ureteroscopy market?

The increasing prevalence of urological diseases and the development of technologically advanced and minimally invasive products are among the factors contributing to market growth.

The List of Companies - Cystoscopy and Ureteroscopy Market

  1. Olympus Corp
  2. Karl Storz SE & Co KG
  3. Richard Wolf GmbH
  4. Ambu A/S
  5. PENTAX Medical
  6. Advin Health Care Pvt Ltd
  7. Coloplast Corp
  8. Cook Medical Holdings LLC
  9. Electronics Services Centre (ESC Medicams)
  10. Stryker Corp
  11. Rudra Surgicals
  12. Laborie
  13. Teleflex Inc
  14. NIDHI MEDITECH SYSTEMS
  15. Pioneer Healthcare Technologies
  16. Boston Scientific Corp
  17. Ottomed Endoscopy
  18. Becton Dickinson and Co
  19. SCHÖLLY FIBEROPTIC GMBH
  20. MicroPort Scientific Corp

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Cystoscopy and Ureteroscopy Market